TRIM28 and neoplasm: Our findings align with these observations, as we demonstrate that overexpressing TRIM28 in cancer cells leads to the recruitment of functional MDSCs, which subsequently inhibit the function and proliferation of effector T cells in KP tumor-bearing mice, ultimately compromising immune surveillance.